Caxton Associates (UK)’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,806
Closed -$233K 924
2025
Q3
$233K Sell
10,806
-3,801
-26% -$86.4K 0.01% 605
2025
Q2
$321K Sell
14,607
-10,218
-41% -$224K 0.01% 525
2025
Q1
$555K Buy
+24,825
New +$535K 0.02% 453

Other funds holding PGNY

Caxton Associates (UK)'s PGNY Position: Q4 2025 in Review

Caxton Associates (UK) sold out of Progyny (PGNY) in Q4 2025, closing a stake of 10,806 shares — an estimated $233K sold.

Caxton Associates (UK) first reported a position in PGNY in Q1 2025 and held it in 3 quarters. The position peaked at $555K in Q1 2025. 313 funds tracked by Wall St. Rank hold PGNY as of Q4 2025.

  • Caxton Associates (UK) reported no remaining Progyny position as of Q4 2025 after selling out during the quarter.
  • Caxton Associates (UK) sold 10,806 Progyny shares in Q4 2025, an estimated $233K.
  • Caxton Associates (UK) first reported a position in Progyny in Q1 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s Progyny position peaked at $555K in Q1 2025.
  • 313 funds tracked by Wall St. Rank held Progyny as of Q4 2025.

Based on Caxton Associates (UK)'s 13F filing for Q4 2025, filed 13 Feb 2026.